A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III Trial

scientific article published on January 1, 1992

A randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III Trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/0959-8049(93)90572-W
P698PubMed publication ID1332737

P2093author name stringD. Stewart
D. Osoba
D. Warr
J. Pater
J. Latreille
F. Laberge
L. Kaizer
A. Wilan
G. O'Connell
P. Venner
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectCanadaQ16
metoclopramideQ421095
dexamethasoneQ422252
granisetronQ596708
phase III clinical trialQ42824827
P304page(s)33-36
P577publication date1992-01-01
P1433published inEuropean Journal of CancerQ332260
P1476titleA randomised, double-blind comparison of granisetron with high-dose metoclopramide, dexamethasone and diphenhydramine for cisplatin-induced emesis. An NCI Canada Clinical Trials Group Phase III Trial
P478volume29A

Reverse relations

cites work (P2860)
Q55005460A randomized cross-over study of high-dose metoclopramide plus dexamethasone versus granisetron plus dexamethasone in patients receiving chemotherapy with high-dose cisplatin.
Q37039597Antiemetics: an update and the MASCC guidelines applied in clinical practice
Q70785527Dexamethasone improves the efficacy of granisetron in the first 24 h following high-dose cisplatin chemotherapy
Q33571897Granisetron. A pharmacoeconomic evaluation of its use in the prophylaxis of chemotherapy-induced nausea and vomiting
Q40397083Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineoplastic therapy
Q40387103Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilities
Q40655344Treatment of chemotherapy-induced emesis in the 1990s: impact of the 5-HT3 receptor antagonists
Q72522017[Antiemetic treatment and chemotherapy: general review]
Q83944098[Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research]

Search more.